Dr. Suga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
975 Sereno Dr
Vallejo, CA 94589Phone+1 707-651-1077
Summary
- Dr. Jennifer Marie Suga is an Oncologist based in Vallejo, CA, in Hematologic Oncology specializing in Thoracic malignancies. Her medical education was completed at Tufts University School of Medicine, followed by a residency in Internal Medicine at Brown University and a fellowship in Hematology and Medical Oncology at the University of California Davis Health. She has contributed to multiple medical publications and partaken in clinical trials as a Contact and Principal Investigator, notably in lung and breast cancer studies. She was recognized with a Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2011.
Education & Training
- University of California Davis HealthFellowship, Hematology and Medical Oncology, 2010
- Brown UniversityResidency, Internal Medicine, 2004 - 2007
- Tufts University School of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2007 - 2026
- RI State Medical License 2005 - 2007
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy Start of enrollment: 2009 May 01
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsFinancial Hardship Among Patients With Early-Stage Colorectal Cancer.Gelareh Sadigh, Fenghai Duan, Na An, Ilana D Gareen, JoRean Sicks
JAMA Network Open. 2024-09-03 - 2 citationsMachine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.Lujia Chen, Ying Wang, Chunhui Cai, Ying Ding, Rim S Kim
Journal of Clinical Oncology. 2024-05-01 - 5 citationsPatient-Reported Financial Burden of Treatment for Colon or Rectal Cancer.Sheetal Kircher, Fenghai Duan, Na An, Ilanan F Gareen, JoRean D Sicks
JAMA Network Open. 2024-01-02
Press Mentions
- Major Financial Hardship Common After Cancer Diagnosis, Despite InsuranceJanuary 4th, 2022
- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: